Science & Nature
Aquila Bioscience Technology
Founded in 2012 at the National University of Ireland, Galway, Aquila Bioscience utilises an innovative technology to remove harmful pathogens in the form of Pathogen Capturing Technology (PCT).
Applied to our first product: the ABD Device which is offered in the form of a decontamination wipe, the pathogen capturing technology is highly effective in capturing and removing viruses like Coronavirus from human skin and sensitive surfaces.
Instead of trying to destroy the virus, complex glyco-sugars are infused in the wipe material, which then acts as a magnet, using natural and irreversible binding interactions to capture the pathogen, effectively neutralising it. Alternatively, the technology acts in a Velcro like fashion to capture the pathogen and prevents contamination which is demonstrated in the image below. To learn more about our technology and how its applied click here
Our product the ABD Device, which stands for the Anti Bioagent Decontamination Device is registered as a Class I Medical Device.
Possessing no alcohol or toxic chemicals, the ABD Device is safe to use human skin and sensitive surfaces and has been proven to remove up to 99.99% of SARS CoV-2 the causing agent of Covid-19.
The ABD Device comes in the form of a decontamination wipe that enables users to safely capture and remove up to 99.99% of SARS CoV-2 the causing agent of Covid -19 from sensitive surfaces and the human skin.
Currently being used in everyday and emergency use cases by Defence Force Ireland, the HSE and An Post
This product is only available to purchase by organisations at present.